Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Baldness score can't be used to predict prostate size.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Early balding at 40 increases prostate cancer risk.

Higher DHT in male baldness may protect against prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Vertex pattern hair loss linked to higher prostate cancer risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Dutasteride may help shrink prostate cancer tumors.

Physical activity, height, and smoking affect prostate cancer risk.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Using finasteride with TIP extends time off period for prostate cancer patients.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.